Status: current, Defined. Date: 30-Jun 2016. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2956131000168117 | Caelyx (doxorubicin hydrochloride (as pegylated liposomal) 20 mg / 10 mL) injection, 10 x 10 mL vials (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2956141000168114 | Caelyx 20 mg/10 mL injection, 10 x 10 mL vials | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Caelyx (doxorubicin hydrochloride (as pegylated liposomal) 20 mg / 10 mL) injection, 10 x 10 mL vials (trade product pack) | Is a | trade product pack | true | Inferred relationship | Some | ||
| Caelyx (doxorubicin hydrochloride (as pegylated liposomal) 20 mg / 10 mL) injection, 10 x 10 mL vials (trade product pack) | Is a | doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, 10 x 10 mL vials | true | Inferred relationship | Some | ||
| Caelyx (doxorubicin hydrochloride (as pegylated liposomal) 20 mg / 10 mL) injection, 10 x 10 mL vials (trade product pack) | has TPUU | Caelyx 20 mg/10 mL injection, 10 mL vial | true | Inferred relationship | Some | 1 | |
| Caelyx (doxorubicin hydrochloride (as pegylated liposomal) 20 mg / 10 mL) injection, 10 x 10 mL vials (trade product pack) | has TP | Caelyx | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Caelyx 20 mg/10 mL injection, 10 x 10 mL vials | Is a | True | Caelyx (doxorubicin hydrochloride (as pegylated liposomal) 20 mg / 10 mL) injection, 10 x 10 mL vials (trade product pack) | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR